Who owns Anika Therapeutics, Inc. (ANIK)? Elite investor 13F holders
3 tracked elite investors reported holding Anika Therapeutics, Inc as of 2026-06-30, including Caligan Partners, Renaissance Technologies LLC, D.E. Shaw. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
3 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Health Care Equipment & Services
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Caligan Partners | ANIKA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 20995952.00 USD | 1435130.000000 | Shares | hold | Original filing |
| Renaissance Technologies LLC | ANIKA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 7043131.00 USD | 481417.000000 | Shares | reduce | Original filing |
| D.E. Shaw | ANIKA THERAPEUTICS INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 3585316.00 USD | 245066.000000 | Shares | add | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.